New Zealand markets open in 7 hours 10 minutes

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
135.90-2.45 (-1.77%)
As of 10:50AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 21.90B
Enterprise value 23.39B
Trailing P/E N/A
Forward P/E 55.87
PEG ratio (5-yr expected) 1.19
Price/sales (ttm)4.88
Price/book (mrq)3.34
Enterprise value/revenue 5.24
Enterprise value/EBITDA -6.63

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-28.50%
S&P500 52-week change 317.14%
52-week high 3248.87
52-week low 3135.70
50-day moving average 3172.20
200-day moving average 3198.57

Share statistics

Avg vol (3-month) 31.59M
Avg vol (10-day) 32M
Shares outstanding 5158.3M
Implied shares outstanding 6158.3M
Float 8157.95M
% held by insiders 10.27%
% held by institutions 193.53%
Shares short (30 Aug 2023) 45.64M
Short ratio (30 Aug 2023) 44.38
Short % of float (30 Aug 2023) 43.99%
Short % of shares outstanding (30 Aug 2023) 43.56%
Shares short (prior month 30 Jul 2023) 45.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 322 Sept 2008

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)01 Jul 2023


Profit margin -93.83%
Operating margin (ttm)-3.86%

Management effectiveness

Return on assets (ttm)-0.79%
Return on equity (ttm)-49.25%

Income statement

Revenue (ttm)4.46B
Revenue per share (ttm)28.32
Quarterly revenue growth (yoy)1.20%
Gross profit (ttm)3.15B
Net income avi to common (ttm)-4.19B
Diluted EPS (ttm)-26.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.56B
Total cash per share (mrq)9.85
Total debt (mrq)3.05B
Total debt/equity (mrq)46.50%
Current ratio (mrq)1.40
Book value per share (mrq)41.49

Cash flow statement

Operating cash flow (ttm)210M
Levered free cash flow (ttm)39.38M